Not logged in.png)
Share.png)
SaveShare Save Share Save BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program
Kim, Dae-Hwan; Sun, Duanchen; Storck, William K.; Leng, Katherine Welker; Jenkins, Chelsea; Coleman, Daniel J.; Sampson, David; Guan, Xiangnan; Kumaraswamy, Anbarasu; Rodansky, Eva S.; Urrutia, Joshua A.; Schwartzman, Jacob A.; Zhang, Chao; Beltran, Himisha; Labrecque, Mark P.; Morrissey, Colm; Lucas, Jared M.; Coleman, Ilsa M.; Nelson, Peter S.; Corey, Eva; Handelman, Samuel K.; Sexton, Jonathan Z.; Aggarwal, Rahul; Abida, Wassim; Feng, Felix Y.; Small, Eric J.; Spratt, Daniel E.; Bankhead, Armand, III; Rao, Arvind; Gesner, Emily M.; Attwell, Sarah; Lakhotia, Sanjay; Campeau, Eric; Yates, Joel A.; Xia, Zheng; Alumkal, Joshi J. Share Save Share Save Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemiaJenkins, Chelsea; Luty, Samuel B.; Maxson, Julia E.; Eide, Christopher A.; Abel, Melissa L.; Togiai, Corinne; Nemecek, Eneida R.; Bottomly, Daniel; McWeeney, Shannon K.; Wilmot, Beth; Loriaux, Marc; Chang, Bill H.; Tyner, Jeffrey W. Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}